retatrutide pricing Just Got Real: Here's Eli Lilly's Strategy Demand for Unapproved Weight-Loss Drug

Tirzepatide delivers proven, FDA-approved results with years of safety data behind it

Asia-Pacific is the fastest-growing regional GLP-1 drug market at 22.6% CAGR , driven by rapidly rising obesity prevalence China now reports 18.6% adult obesity prevalence up from 7.1% in 2000 combined with expanding private health insurance and regulatory approvals

August 15, 2025

Does PlexusDx require insurance to access compounded GLP-1

A multiphase optimization strategy, however, enables researchers to assess the contributions of individual intervention components by allowing them to identify from a set of components the combination that best demonstrates effectiveness, affordability, scalability, and efficiency (Collins, 2018